Skip to content
PLEASE DONATE Now To Help Get the THIRD Clinical Trial Going!
agt-logo-redirect-page

Menu

  • AGT Investors
  • Pipeline
    • Overview
    • HIV
    • Phenylketonuria (PKU)
    • Immuno-Oncology
  • Technology
    • Overview
    • Rapid Drug Development
    • Genetic Technologies
    • Gamma Delta T Cell Therapy For Cancer – ImmunoTox
  • Resources
    • Blog
    • Newsletters
    • Videos & Audio
    • HIV Cure Countdown
    • The Cure Chronicles
    • DNA Valley
    • Learning for Young Minds
    • AGT Knowledge Base
    • AGT Patents
  • Media
    • News Releases
    • In The News
    • Online Newsroom
  • About Us
    • Overview
    • Leadership Team
    • Scientific & Clinical Advisors
    • In Memoriam: Dr. Roscoe Brady
    • History
    • Contact Us
  • Careers
  • Donations

Methods of Producing Cells Resistant to HIV Infection

Read More

Non-Integrating Viral Delivery System and Methods of Use Thereof

Read More

HIV Pre-Immunization and Immunotherapy JP

Read More

Immunotherapy, No Pre-Immunization, HIV(+) Patients KR

Read More

Immunotherapy, No Pre-Immunization, HIV(+) Patients JP

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients JP

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients IL

Read More

Pre-Immunization and Immunotherapy in HIV(+) Patients IL

Read More
« Newer Posts
Older Posts »

Follow AGT on Social Media

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

AGT on Facebook

American Gene Technologies

1 years ago

American Gene Technologies
Jeff Galvin, CEO of American Gene Technologies, shares his journey from Silicon Valley to biotech and the future of gene therapy. Watch the interview on Bio Blast!www.addimmune.com/jeff-galvin-explains-agts-innovative-approach-to-hiv-on-bio-blast/#genetherapy #biotech #innovation ... See MoreSee Less

Photo

View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

American Gene Technologies

1 years ago

American Gene Technologies
Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. loom.ly/96TZ0jU#HIV #celltherapy #biotech ... See MoreSee Less

Photo

View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

American Gene Technologies

1 years ago

American Gene Technologies
M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest. ... See MoreSee Less

Photo

View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

American Gene Technologies

1 years ago

American Gene Technologies
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on the research and what lies ahead in our mission to find a cure for HIV! loom.ly/jAThqIU#HIV #hivcure #HIVresearch #clinicaltrials ... See MoreSee Less

Photo

View on Facebook
· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Get In Touch

American Gene Technologies Inc.

9713 Key West Ave, 5th floor, Rockville, MD 20850

Phone: (301) 337-2100

Fax: (301) 337-2101

Follow Us on Social Media

Contact Us

Sign-up For Our Newsletter

We send out quarterly newsletters that keep you up-to-date on all our projects, progress, and events.

Sign-up For Our Newsletter

We send out quarterly newsletters that keep you up-to-date on all our projects, progress, and events.

Sign-Up For Our Newsletter

Follow Us on Social Media

Investors

  • Corporate Profile
  • Schedule Investor Relations Appointment
  • +1 (410)-703-7300

Pipeline

  • Overview
  • HIV
  • Phenylketonuria (PKU)
  • Immuno-Oncology

Technology

  • Overview
  • Rapid Drug Development
  • Genetic Technologies
  • Gamma Delta T Cell Therapy For Cancer – ImmunoTox

Media

  • In The News
  • AGT Newsletters
  • Videos & Audio
  • Gene and Cell Therapy for Young Minds
  • News Releases
  • Blog

About Us

  • Overview
  • Leadership Team
  • Scientific & Clinical Advisors
  • In Memoriam: Dr. Roscoe Brady
  • History
  • Careers
  • Contact Us

Have a question? Visit our knowledge base for instant and current answers.

Copyright © 2025 American Gene Technologies® | Privacy Policy

  • AGT Investors
  • Pipeline
    • Overview
    • HIV
    • Phenylketonuria (PKU)
    • Immuno-Oncology
    • Back
  • Technology
    • Overview
    • Rapid Drug Development
    • Genetic Technologies
    • Gamma Delta T Cell Therapy For Cancer – ImmunoTox
    • Back
  • Resources
    • Blog
    • Newsletters
    • Videos & Audio
    • HIV Cure Countdown
    • The Cure Chronicles
    • DNA Valley
    • Learning for Young Minds
    • AGT Knowledge Base
    • AGT Patents
    • Back
  • Media
    • News Releases
    • In The News
    • Online Newsroom
    • Back
  • About Us
    • Overview
    • Leadership Team
    • Scientific & Clinical Advisors
    • In Memoriam: Dr. Roscoe Brady
    • History
    • Contact Us
    • Back
  • Careers
  • Donations
  • Search
Scroll To Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy